biotherapeutic
Impact of Live Biotherapeutic Products on C. difficile Recurrence
It is estimated that 500,000 people in the United States test positive for Clostridioides difficile infection (CDI) ...
NOVEMBER 17, 2022
VRBPAC Recommends Ferring’s Biotherapeutic to Reduce Recurrent CDI
The FDA Advisory Committee, VRBPAC issued a positive vote recommending Ferring’s biotherapeutic to reduce ...
SEPTEMBER 23, 2022
Load more